LP
AMPE

LMR Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

LMR Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-232
Closed -$4K – 1596
2022
Q3 		$4K Hold
232
– – ﹤0.01% 1198
2022
Q2 		$12K Buy
+232
New +$17.3K ﹤0.01% 1255
2021
Q2 		– Sell
-380
Closed -$192K – 1514
2021
Q1 		$192K Buy
+380
New +$196K ﹤0.01% 796
2019
Q4 		– Sell
-103
Closed -$16K – 601
2019
Q3 		$16K Hold
103
– – ﹤0.01% 405
2019
Q2 		$12K Buy
+103
New +$16.3K ﹤0.01% 411
2017
Q3 		– Sell
-525
Closed -$82K – 600
2017
Q2 		$82K Buy
+525
New +$106K 0.01% 571
2015
Q3 		– Sell
-155
Closed -$110K – 531
2015
Q2 		$110K Buy
155
+93
+150% +$99.1K 0.01% 442
2015
Q1 		$141K Buy
+62
New +$106K 0.02% 368

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

LMR Partners's AMPE Position: Q4 2022 in Review

LMR Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 232 shares — an estimated $4K sold.

LMR Partners first reported a position in AMPE in Q1 2015 and held it in 8 quarters. The position peaked at $192K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • LMR Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 232 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $4K.
  • LMR Partners first reported a position in Ampio Pharmaceuticals Inc. in Q1 2015 and held it in 8 quarters.
  • LMR Partners's Ampio Pharmaceuticals Inc. position peaked at $192K in Q1 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.